JP Morgan Chase & Co’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $487K | Sell |
|
|||||
|
2025
Q2 | $564K | Buy |
|
|||||
|
2025
Q1 | $191K | Sell |
|
|||||
|
2024
Q4 | $210K | Sell |
|
|||||
|
2024
Q3 | $455K | Buy |
|
|||||
|
2024
Q2 | $109K | Sell |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $1.06M | Sell |
|
|||||
|
2023
Q3 | $1.67M | Sell |
|
|||||
|
2023
Q2 | $4.1M | Buy |
|
|||||
|
2023
Q1 | $2.98M | Buy |
|
|||||
|
2022
Q4 | $1.84M | Buy |
|
|||||
|
2022
Q3 | $542K | Buy |
|
|||||
|
2022
Q2 | $118K | Buy |
|
|||||
|
2022
Q1 | $58K | Buy |
|